Sukhatme Mayukh

President & CIO, DirectorRoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Aug 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$24.2M
Net Open-Market Flow
-$24.2M
Transactions
11
8 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2026Option exercise(M)32K$3.85$122K18.7M
Aug 18, 2026Sell(S)32K$37.18$1.2M18.6M
Aug 18, 2026Option exercise(M)105K$3.85$405K18.7M
Aug 18, 2026Sell(S)105K$36.59$3.8M18.6M
Aug 17, 2026Option exercise(M)285K$3.85$1.1M18.9M
Aug 17, 2026Sell(S)285K$36.25$10.3M18.6M
Aug 14, 2026Option exercise(M)243K$3.85$936K18.9M
Aug 14, 2026Sell(S)243K$36.23$8.8M18.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 18, 2026Option exercise(M)137K$013.6M
Aug 17, 2026Option exercise(M)285K$013.7M
Aug 14, 2026Option exercise(M)243K$014.0M

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-033637) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ROIV insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001140361-26-033637"
Ask your agent
Use Arkolith to summarize insider buying and selling at Roivant Sciences Ltd.
over the last 90 days and cite the filings.